Skip to main content

1 Result(s)

within Anne-Kristina Mercier Remove this filter English Remove this filter Gastroenterology Remove this filter

and

  1. Article

    Open Access

    Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn’s disease

    Short-term efficacy and safety of brazikumab (MEDI2070), a human monoclonal antibody and anti-p19 subunit inhibitor of interleukin-23, was demonstrated in a phase 2a trial in patients with moderate-to-severe a...

    Silvio Danese, Andrew Beaton, Elizabeth A. Duncan… in BMC Gastroenterology (2023)

    Download PDF (1401 KB) View Article